España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
oops!
The page you were looking for could not be found...
Symbol Similar to:
BMAC
No similar symbols found
Top Gaining Stocks
AEON
AEON Biopharma
$1.87
2672.59%
ENVB
Enveric Biosciences
$3.38
186.43%
TRNR
Interactive Strength
$2.01
111.61%
QVCGB
QVC Group
$9.35
84.14%
HCTI
Healthcare Triangle
$0.63
67.07%
Session: Feb 25, 2025 4:00PM EST - Feb 26, 2025 9:51AM EST
Popular News
Lowe's Q4 Win: Higher Profits, Big Buybacks And A Cautious 2025 Outlook
Nvidia Stock Stumbles Into Q4 Earnings: Can It Defy NVDA Bears?
Bitcoin Is 'A Better Store Of Value Than Gold' Says Expert As El Salvador, Metaplanet Buy-The-Dip
US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert
Trump Negotiates A 'Very Big Deal' For Ukraine's Mineral Wealth, But Lacks Long-Term Security Guarantees: Report
SMCI Stock Pops Over 26% In Wednesday Pre-Market After Super Micro Computer Says It 'Regained Compliance'
Whales Dump Melania Memecoin At Heavy Losses As Market Meltdown Wipes Out $12 Billion In Investor Wealth
Nasdaq Dips Over 1% Ahead Of Nvidia Earnings: Greed Index Moves To 'Extreme Fear' Zone
Tesla Loses $1 Trillion Valuation As Shares Plunge 8%— Elon Musk's DOGE Role, Brand Backlash Fuel Sell-Off
Meta Gears Up For AI Dominance With $200 Billion Data Center Project: Report
Cathie Wood Buys The Dip In Tempus AI, Coinbase But Sells Ark's Bitcoin ETF Shares Amid Crypto Meltdown
AMC Q4 Earnings: Revenue Beat, EPS In Line, Attendance Up 20%, Shares Climb
Lucid Q4 Earnings: Revenue Beat, EPS Beat, 20K Production Guidance For 2025, CEO Transition And More
Market Could Enter A 'Real Correction,' Expert Warns, Highlights 2 'Recession-Resistant' Companies
Apple Shareholders Uphold DEI Programs Amid Corporate Rollbacks
